U.S. Electronic Equipment and Components Stock News

MongoDB (NasdaqGM:MDB) has appointed Ryan Mac Ban as Chief Revenue Officer. The new CRO is tasked with driving the next phase of growth in AI and cloud data markets. This leadership change follows other recent executive additions at the company. For investors watching MongoDB, the new CRO role sits at the center of how the company turns demand for AI and multi cloud data platforms into actual revenue. MongoDB focuses on modern database and developer data tools that are widely used in cloud...

Wondering whether Prosperity Bancshares at around US$66 is offering good value today, or if the price already reflects its strengths? This article breaks down what the numbers are really saying about the stock. The share price is around US$66.41 after a recent 2.9% gain over the last 7 days, set against a 9.7% decline over 30 days and a 4.6% decline year to date and over 1 year, with a 3 year return of 18.6% and 5 year return of 2.8%. Recent coverage has focused on how Prosperity Bancshares...

If you are wondering whether Ocugen's current share price still makes sense after a strong run, the key question is how that price lines up with the underlying value of the business. Ocugen shares, which last closed at US$1.92, have had a mixed but attention grabbing run, with a 21.6% decline over the last 7 days, a 20.0% gain over 30 days, 39.1% year to date, 168.6% over 1 year and 131.3% over 3 years, set against a 71.6% loss over 5 years. Recent news coverage has focused on Ocugen's...

Hesai Group (NasdaqGS:HSAI) has just posted its FY 2025 third quarter numbers, with revenue of C¥795.4 million and basic EPS of C¥1.88 setting the tone for the latest update. The company has seen quarterly revenue move from C¥458.9 million in Q2 2024 to C¥719.8 million in Q4 2024 and then to C¥795.4 million in Q3 2025. Basic EPS has shifted from a loss of C¥0.56 per share in Q2 2024 to C¥1.13 in Q4 2024 and C¥1.88 in Q3 2025, pointing to a business where margins are increasingly in focus for...

Last week's earnings announcement from Turtle Beach Corporation ( NASDAQ:TBCH ) was disappointing to investors, with a...

Two Harbors Investment Corp. (NYSE:TWO) has received unsolicited acquisition proposals that the board is formally reviewing. The board has identified at least one proposal as a potential "Company Superior Proposal" under its existing merger agreement with UWMC. These proposals could affect the outcome of the current merger plan and may alter the future ownership structure of NYSE:TWO. Two Harbors Investment Corp. operates as a real estate investment trust focused on mortgage related assets,...

Wondering whether AppFolio at around US$161.05 still makes sense as an investment, or if the recent price puts it out of your comfort zone on value. The stock has seen a 4.4% decline over the last 7 days, a 6.5% decline over 30 days, and a 30.1% decline year to date and over 1 year, while the 3 year and 5 year returns sit at 34.0% and 16.5% respectively. Recent coverage has focused on how the year to date and 1 year share price performance of 30.1% may be influencing investor sentiment...

Earlier this year, Unum Group expanded its Unum Broker Connect integration with Employee Navigator to add automated billing and eligibility features, aiming to cut manual work and improve accuracy for brokers and employers managing benefits and leave. By automating eligibility data flows into Unum Total Leave, the company is positioning its benefits platform as a more integrated solution for employers grappling with increasingly complex leave management. We’ll now explore how this expanded...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...

Even if it's not a huge purchase, we think it was good to see that Douglas Reynolds, the President of Energy Services...

We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

On March 10, Centrus Energy (NYSE:LEU) adopted amended bylaws addressing new universal proxy rules. The changes clarify shareholder voting standards and tighten requirements for using universal proxy cards in director elections. The board also updated exclusive forum provisions that govern where certain legal disputes must be brought. Centrus Energy is drawing fresh attention after its board revised the company bylaws to align with evolving proxy and legal frameworks. The move comes as the...

We wouldn't blame Viemed Healthcare, Inc. ( NASDAQ:VMD ) shareholders if they were a little worried about the fact that...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

The Morning Bull - US Market Morning Update Wednesday, Mar, 25 2026 US stock futures are pointing higher this morning, with key contracts on the S&P 500 and Nasdaq up around 1%, as investors weigh easing tensions in the Middle East against stubbornly high borrowing costs. The US 10 year Treasury yield is sitting above 4.4%, an eight month high, which means mortgages, car loans and business financing remain expensive. At the same time, fresh US business surveys show manufacturing at 52.4 and...

Wondering whether Box at US$23.60 offers good value or if you are better off waiting on the sidelines? This breakdown will help you see how the current price compares with a range of valuation checks. The share price has been mixed recently, with a 3.5% decline over the last week, a 3.2% gain over the last month, and returns of an 18.1% decline year to date and a 23.3% decline over the last year. Recent headlines around Box have focused on its position in content management and collaboration...

If you are wondering whether DNOW at around US$11.99 is starting to look like value or is still pricing in too much optimism, this breakdown will help you frame the stock through a few clear valuation lenses. The share price has moved 7.8% over the past week but is still showing a 9.4% decline over 30 days, a 10.3% decline year to date and a 29.3% decline over the past year, which can change how the market is thinking about both risk and opportunity. Recent coverage has focused on DNOW’s...